Chemoinformaics analysis of Methyl pheophorbide a
| Molecular Weight | 606.723 | nRot | 6 |
| Heavy Atom Molecular Weight | 568.419 | nRig | 36 |
| Exact Molecular Weight | 606.284 | nRing | 6 |
| Solubility: LogS | -5.533 | nHRing | 5 |
| Solubility: LogP | 6.035 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 83 | No. of Aliphatic Hetero Cycles | 5 |
| No. of Heavy Atom | 45 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 8 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 36 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 4 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 9 | APOL | 93.8681 |
| nHD | 2 | BPOL | 47.3199 |
| QED | 0.304 |
| Synth | 7.062 |
| Natural Product Likeliness | 0.643 |
| NR-PPAR-gamma | 0.548 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.999 |
| Pgp-sub | 0.902 |
| HIA | 0.387 |
| CACO-2 | -5.785 |
| MDCK | 0.00000643 |
| BBB | 0.003 |
| PPB | 0.984916 |
| VDSS | 0.284 |
| FU | 0.0258987 |
| CYP1A2-inh | 0.971 |
| CYP1A2-sub | 0.873 |
| CYP2c19-inh | 0.59 |
| CYP2c19-sub | 0.845 |
| CYP2c9-inh | 0.948 |
| CYP2c9-sub | 0.082 |
| CYP2d6-inh | 0.513 |
| CYP2d6-sub | 0.14 |
| CYP3a4-inh | 0.97 |
| CYP3a4-sub | 0.932 |
| CL | 2.671 |
| T12 | 0.139 |
| hERG | 0.446 |
| Ames | 0.072 |
| ROA | 0.974 |
| SkinSen | 0.751 |
| Carcinogencity | 0.59 |
| EI | 0.007 |
| Respiratory | 0.983 |
| NR-Aromatase | 0.985 |
| Antiviral | Yes |
| Prediction | 0.85578 |